Skip to main content

Table 2 Laboratory findings and imaging results in 159 patients categorized in cancer, and without cancer subgroups and 53 cancerous patients categorized into alive and dead

From: Clinical characteristics, outcomes, and risk factors for mortality in hospitalized patients with COVID-19 and cancer history: a propensity score-matched study

  W/O cancer
N (%)a
Cancer
N (%)
p value Cancer p value
Alive;
N = 26 (%)
Dead;
N = 27 (%)
Covid RT-PCR
 Positive 44 (41.5) 20 (37.7) 0.887 8 (30.8) 12 (44.4) 0.137
Hemoglobin (g/dl)
 < 10 10 (9.4) 24 (45.3) 0.000 10 (38.5) 14 (51.9) 0.404
  > 10 86 (81.1) 28 (52.8)   16 (61.5) 12 (44.4)  
 Missing 10 (9.4) 1 (1.9)   1 (3.7)  
Platelet (/microliter)
 < 150,000 24 (22.6) 29 (54.7) 0.000 10 (38.5) 19 (70.4) 0.025
  > 150,000 71 (67) 23 (43.4)   16 (61.5) 7 (25.9)  
 Missing 10 (9.4) 1 (1.9)   1 (3.7)  
WBC (/microliter)
 < 4000 11 (10.4) 15 (28.3) 0.000 8 (30.8) 7 (25.9) 0.779
 4000–12,000 70 (66) 18 (34) 10 (38.4) 8 (29.6)
 > 12,000 15 (14.2) 19 (35.8) 8 (30.8) 11 (40.7)
 Missing 10 (9.4) 1 (1.9) 1 (3.7)
Lymphocyte (/microliter)
 < 1000 34 (32.1) 15 (28.3) 0.082 12 (46.2) 5 (18.5) 0.028
 1000–4000 35 (33) 17 (32.1) 10 (38.4) 5 (18.5)
 > 4000 1 (0.9) 4 (7.5) 0 4 (14.8)
 Missing 36 (34) 17 (32.1) 4 (15.4) 13 (48.2)
Neutrophil (/microliter)
 < 1500 1 (0.9) 7 (13.2) 0.000 5 (19.2) 2 (7.4) 0.908
 1500–7700 52 (49.1) 15 (28.3) 9 (34.6) 6 (22.2)
 > 7700 17 (16) 14 (26.4) 8 (30.8) 6 (22.2)
 Missing 36 (34) 17 (32.1) 4 (15.4) 13 (48.2)
pH
 < 7.25 4 (3.8) 5 (9.4)   1 (3.8) 4 (14.8)  
 7.25–7.35 6 (5.7) 6 (11.3)   3 (11.5) 3 (11.1)  
 7.35–7.45 65 (61.2) 35 (66.1) 0.372 20 (76.9) 15 (55.6) 0.462
 > 7.45 18 (17) 6 (11.3)   2 (7.7) 4 (14.8)  
 Missing 13 (12.3) 1 (1.9)   1 (3.7)  
PCO2 (mmHg)
 < 35 26 (24.5) 16 (30.2) 0.769 5 (19.2) 11 (40.7) 0.008
 35–45 41 (38.7) 19 (35.9) 15 (57.7) 4 (14.8)
 > 45 24 (22.6) 14 (26.4) 5 (19.2) 9 (33.3)
 Missing 15 (14.2) 4 (7.5) 1 (3.8) 3 (11.1)
HCO3 (mEq/L)
 < 22 23 (21.7) 21 (39.6) 0.100 6 (23.1) 15 (55.6) 0.018
 22–26 30 (28.3) 13 (24.6) 10 (38.4) 3 (11.1)
 > 26 38 (35.8) 15 (28.3) 9 (34.6) 6 (22.2)
 Missing 15 (14.2) 4 (7.5) 1 (3.8) 3 (11.1)
Na (mEq/L)
 < 135 16 (15.1) 9 (17) 0.739 5 (19.2) 4 (14.8) 0.790
 135–145 76 (71.7) 40 (75.5) 19 (73.1) 21 (77.8)
 > 145 3 (2.8) 3 (5.6) 2 (7.7) 1 (3.7)
 Missing 11 (10.4) 1 (1.9) 1 (3.7)
K (mEq/L)
 < 3.5 5 (4.7) 3 (5.6) 0.985 1 (3.8) 2 (7.4) 0.501
 3.5–5 76 (71.7) 40 (75.5) 22 (84.6) 18 (66.7)
 > 5 15 (14.2) 8 (15.1) 3 (11.5) 5 (18.5)
 Missing 10 (9.4) 2 (3.8) 2 (7.4)
AST (IU/L)
  < 40 38 (35.8) 14 (26.4)   8 (30.8) 6 (22.2)  
 > 40 34 (32.1) 31 (58.5) 0.022 16 (61.5) 15 (55.6) 0.759
 Missing 34 (32.1) 8 (15.1)   2 (7.7) 6 (22.2)  
ALT (IU/L)
  < 40 53 (50) 28 (52.8) 0.181 15 (57.7) 13 (48.2) 0.990
 > 40 20 (18.9) 18 (34)   9 (34.6) 9 (33.3)  
 Missing 33 (31.1) 7 (13.2)   2 (7.7) 5 (18.5)  
ALK-p (IU/L)
  < 200 46 (43.4) 14 (26.4)   7 (26.9) 7 (25.9)  
 > 200 24 (22.6) 31 (58.5) 0.000 16 (61.5) 15 (55.6) 0.990
 Missing 36 (34) 8 (15.1)   3 (11.5) 5 (18.5)  
PTT (seconds)
  < 45 70 (66) 37 (69.8)   19 (73.1) 18 (66.7)  
 > 45 2 (1.9) 3 (5.6) 0.246 3 (11.5) 0 0.238
 Missing 34 (32.1) 13 (24.6)   4 (15.4) 9 (33.3)  
INR
  < 1.5 60 (56.6) 26 (49.1)   13 (50) 13 (48.2)  
 > 1.5 14 (13.2) 19 (35.8) 0.006 10 (38.4) 9 (33.3) 0.990
 Missing 32 (30.2) 8 (15.1)   3 (11.5) 5 (18.5)  
Total Bilirubin (mg/dl)
  < 1.5 47 (44.3) 20 (37.7)   12 (46.1) 8 (29.6)  
 > 1.5 7 (6.6) 16 (30.2) 0.001 6 (23.1) 10 (37) 0.315
 Missing 52 (49.1) 17 (32.1)   8 (30.8) 9 (33.3)  
Creatinine (mg/dl)
  < 1.2 69 (65.1) 35 (66)   19 (73.1) 16 (59.3)  
 > 1.2 28 (26.4) 17 (32.1) 0.628 7 (26.9) 10 (37) 0.375
 Missing 9 (8.5) 1 (1.9)   1 (3.7)  
 CRP¥ (mg/L) 68.7 (27; 82) 79 (43; 98) 0.033 70 (19.5;101.5) 79 (76.5;95) 0.282
  1. WBC White blood cell, AST aspartate aminotransferase, ALT alanine aminotransferase, ALK-P Alkaline Phosphatase, PTT activated partial thromboplastin time, INR international normalized ratio, CRP C-reactive protein, GGO ground glass opacity
  2. a Percentages were calculated by the number of total, alive, and dead patients as denominator for each column respectively